CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6

Cancer Immunology, Immunotherapy

Volumn 50, Issue 4, 2001, Pages 173-180

  Hicks, Christine ^a   Keoshkerian, Elizabeth ^a   Gaudry, Leonie ^a   Lindeman, Robert ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

B7 1; Co stimulation; Differentiation; Immunogenicity; Leukaemia

Indexed keywords

B7 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL KILLING; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOGENETICS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LEUKEMIA CELL; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIGENS, CD80; CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-3; INTERLEUKIN-6; LEUKEMIA, MYELOID; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0034912220     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006686     Document Type: Article

References (50)

1. Involvement of CD28 in MHC-unrestricted cytotoxicity-mediated by a human natural killer leukemia cell line
2. Major histocompatibility complex class II and B7-B1 tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice
3. Constitutive expression of B7 restores immunogenicity of tumour cells expressing truncated MHC class II molecules
4. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells
5. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia
6. Colony assay for proliferative blast cells circulating in myeloblastic leukemia
7. The nature and action of granulocyte-macrophage colony stimulating factor
8. Costimulation of antitumour immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4
9. Tumour immunogenicity determines the effect of B7 costimulation on T-cell-mediated tumour immunity
10. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, anti-leukemic T-cell responses
11. Studies of cellular proliferation in human leukemia III. Behaviour of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days
12. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture
13. Regulation of CD80/B7-B1 and CD 86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogeneic immune regulation
14. B7-1 dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells
15. Gene therapy vaccines in acute myeloid leukemia: A need for clinical evaluation
16. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML
17. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia
18. Expression of oncogenes and cell cycle related genes in acute and chronic leukemias
19. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway
20. Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures
21. Use of surface markers to identify a subset of acute myelomonocytic leukemia cells, with progenitor cell properties
22. Protective and therapeutic immunity against leukemia induced by irradiated B7-B1 (CD80) transduced leukemic cells
23. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1
24. Interleukin-6 enhances growth factor dependent proliferation of the blast cells of acute myeloblastic leukemia
25. Induction of antitumor immunity by recombinant Vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules
26. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of interferon-gamma modulation of accessory cells for physical interaction with T cells
27. Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity
28. Control of in vivo differentiation of myeloid leukemic cells
29. Human chronic myelogenous leukemic cell line with positive Philadelphia chromosome
30. Characterisation of human adult marrow hematopoeitic progenitors highly enriched by two-colour cell sorting with My10 and major histocompatibility antigens
31. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia
32. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity
33. Role of B7-1 in mediating an immune response to myeloid leukemia cells
34. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed against patient specific minor histocompatibility antigens and leukemia-associated antigens
35. T cell costimulation of B7/BB1 induces CD8 T cell-dependent tumour rejection: An important role of B7/BB1 in the induction, recruitment and effector function of anti-tumour T cells
36. Characteristics of an established cell line of retinoblastoma
37. The in-vitro generation of dendritic cells from blast cells in acute leukaemia
38. Proof of malignant clone of origin of dendritic cells growing in culture from a patient with del(5)(q13q33) acute mixed lineage leukemia
39. The control of growth and differentiation in normal and leukemic blood cells. The 1989 Alfred P Sloan Prize of the General Motors Cancer Research Foundation
40. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia
41. Variation of proliferative activity in leukemic cell populations of patients with acute leukemia
42. The myeloid blood cell differentiation-inducing protein MG1-2A is interleukin-6
43. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses
44. Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony stimulating factor
45. Establishment and characterisation of a human histocytic lymphoma cell line (U937)
46. Characterisation and partial purification of human marrow cells capable of initiating long-term hematopoeisis in vitro
47. + T cells by B7 transfected melanoma cells
48. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells
49. Lactate dehydrogenase-release assay: A reliable nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia
50. On the maturation order of AML cells; a distinction on the basis of self-renewal properties and immunologic phenotypes